Drug Combination of Ciprofloxacin and Polymyxin B for the Treatment of Multidrug–Resistant <i>Acinetobacter baumannii</i> Infections: A Drug Pair Limiting the Development of Resistance
Polymyxins are considered as last–resort antibiotics to treat infections caused by <i>Acinetobacter baumannii</i>. However, there are increasing reports of resistance in <i>A. baumannii</i> to polymyxins. In this study, inhalable combinational dry powders consisting of ciprof...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/3/720 |